SG10201400716PA - Non-human transgenic animals expressing humanised antibodies and use therof - Google Patents

Non-human transgenic animals expressing humanised antibodies and use therof

Info

Publication number
SG10201400716PA
SG10201400716PA SG10201400716PA SG10201400716PA SG10201400716PA SG 10201400716P A SG10201400716P A SG 10201400716PA SG 10201400716P A SG10201400716P A SG 10201400716PA SG 10201400716P A SG10201400716P A SG 10201400716PA SG 10201400716P A SG10201400716P A SG 10201400716PA
Authority
SG
Singapore
Prior art keywords
transgenic animals
human transgenic
animals expressing
humanised antibodies
use therof
Prior art date
Application number
SG10201400716PA
Inventor
Roger Kingdon Craig
Franklin Gerardus Grosveld
Richard Wilhelm Janssens
Haperen Maπnus Johannes Van
Original Assignee
Univ Erasmus Medical Ct
Kingdon Craig R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0823147A external-priority patent/GB0823147D0/en
Priority claimed from GB0906673A external-priority patent/GB0906673D0/en
Priority claimed from GB0909207A external-priority patent/GB0909207D0/en
Priority claimed from GB0909208A external-priority patent/GB0909208D0/en
Application filed by Univ Erasmus Medical Ct, Kingdon Craig R filed Critical Univ Erasmus Medical Ct
Publication of SG10201400716PA publication Critical patent/SG10201400716PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Humanized animals, e.g. knockin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knockout animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A01K2217/206—Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
SG10201400716PA 2008-12-18 2009-11-30 Non-human transgenic animals expressing humanised antibodies and use therof SG10201400716PA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0823147A GB0823147D0 (en) 2008-12-18 2008-12-18 Allele selection |||
GB0906673A GB0906673D0 (en) 2009-04-17 2009-04-17 Allele selection iv
GB0909207A GB0909207D0 (en) 2009-05-28 2009-05-28 Allele Selection I
GB0909208A GB0909208D0 (en) 2009-05-28 2009-05-28 Allele selection II

Publications (1)

Publication Number Publication Date
SG10201400716PA true SG10201400716PA (en) 2014-09-26

Family

ID=41818841

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2011043775A SG172176A1 (en) 2008-12-18 2009-11-30 Non-human transgenic animals expressing humanised antibodies and use therof
SG10201400716PA SG10201400716PA (en) 2008-12-18 2009-11-30 Non-human transgenic animals expressing humanised antibodies and use therof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2011043775A SG172176A1 (en) 2008-12-18 2009-11-30 Non-human transgenic animals expressing humanised antibodies and use therof

Country Status (15)

Country Link
US (3) US20110314563A1 (en)
EP (1) EP2379727B1 (en)
JP (1) JP5827127B2 (en)
KR (1) KR101711222B1 (en)
CN (6) CN112680475A (en)
AU (1) AU2009329365B2 (en)
BR (1) BRPI0922479A2 (en)
CA (1) CA2747534C (en)
DK (1) DK2379727T3 (en)
ES (1) ES2613730T3 (en)
MX (1) MX2011007660A (en)
RU (1) RU2011129459A (en)
SG (2) SG172176A1 (en)
TW (1) TW201030143A (en)
WO (1) WO2010070263A1 (en)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ592308A (en) 2008-09-30 2012-11-30 Ablexis Llc Non-human mammals for the production of chimeric antibodies
CN112680475A (en) * 2008-12-18 2021-04-20 伊拉兹马斯大学鹿特丹医学中心 Non-human transgenic animals expressing humanized antibodies and uses thereof
US9445581B2 (en) 2012-03-28 2016-09-20 Kymab Limited Animal models and therapeutic molecules
US20120204278A1 (en) 2009-07-08 2012-08-09 Kymab Limited Animal models and therapeutic molecules
WO2011158009A1 (en) * 2010-06-17 2011-12-22 Kymab Limited Animal models and therapeutic molecules
BR112012000536A2 (en) * 2009-07-08 2020-08-11 Kymab Limited methods for producing antibody or light or heavy chain of antibody specific to a desired antigen, for producing antibody or antibody chain and its use, pharmaceutical composition and chimeric antibody derivative
ES2547142T5 (en) 2010-02-08 2021-12-09 Regeneron Pharma Mouse common light chain
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
NZ601171A (en) 2010-03-31 2014-11-28 Ablexis Llc Genetic engineering of non-human animals for the production of chimeric antibodies
SI2480675T1 (en) * 2010-06-22 2016-08-31 Regeneron Pharmaceuticals, Inc. Mice expressing a light chain with human lambda variable and mouse constant regions
NZ606824A (en) 2010-08-02 2015-05-29 Regeneron Pharma Mice that make binding proteins comprising vl domains
HUE024534T2 (en) 2011-02-25 2016-01-28 Regeneron Pharma Adam6 mice
US9920110B2 (en) 2011-03-09 2018-03-20 Cell Signaling Technology, Inc. Methods and reagents for creating monoclonal antibodies
IL297371A (en) 2011-08-05 2022-12-01 Regeneron Pharma Humanized universal light chain mice
AU2012311286B2 (en) 2011-09-19 2018-07-26 Kymab Limited Antibodies, variable domains and chains tailored for human use
JP2014531452A (en) 2011-09-19 2014-11-27 カイマブ・リミテッド Animals, repertoire and methods
EP2761008A1 (en) 2011-09-26 2014-08-06 Kymab Limited Chimaeric surrogate light chains (slc) comprising human vpreb
HUE057680T2 (en) 2011-10-17 2022-06-28 Regeneron Pharma Restricted immunoglobulin heavy chain mice
US9253965B2 (en) 2012-03-28 2016-02-09 Kymab Limited Animal models and therapeutic molecules
SI2793567T1 (en) 2011-12-20 2019-05-31 Regeneron Pharmaceuticals, Inc. Humanized light chain mice
US9175072B2 (en) 2011-12-22 2015-11-03 Elwha Llc Compositions and methods including recombinant B lymphocyte cell line including an exogenously incorporated nucleic acid expressing an exogenous membrane immunoglobulin reactive to a first antigen and including an endogenous gene expressing an endogenous secreted immunoglobulin reactive to a second antigen
US10233424B2 (en) 2011-12-22 2019-03-19 Elwha Llc Compositions and methods including cytotoxic B lymphocyte cell line expressing exogenous membrane immunoglobulin different from secreted immunoglobulin
US8962315B2 (en) * 2011-12-22 2015-02-24 Elwha Llc Compositions and methods including recombinant B lymphocyte cell line including at least one endogenous gene expressing at least one endogenous membrane immunoglobulin reactive to a first antigen and including at least one exogenously incorporated nucleic acid expressing at least one exogenous secreted immunoglobulin reactive to a second antigen
US10745468B2 (en) 2011-12-22 2020-08-18 Kota Biotherapeutics, Llc Compositions and methods for modified B cells expressing reassigned biological agents
HUE037659T2 (en) 2012-03-16 2018-09-28 Regeneron Pharma Histidine engineered light chain antibodies and genetically modified rodents for generating the same
NZ629077A (en) 2012-03-16 2015-12-24 Regeneron Pharma Non-human animals expressing ph-sensitive immunoglobulin sequences
KR20140134672A (en) 2012-03-16 2014-11-24 리제너론 파마슈티칼스 인코포레이티드 Mice that produce antigen-binding proteins with ph-dependent binding characteristics
US20140013456A1 (en) 2012-03-16 2014-01-09 Regeneron Pharmaceuticals, Inc. Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
US10251377B2 (en) 2012-03-28 2019-04-09 Kymab Limited Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
WO2013144567A1 (en) 2012-03-28 2013-10-03 Kymab Limited Transgenic non-human vertebrate for the expression of class - switched, fully human, antibodies
EP3912464A1 (en) 2012-06-12 2021-11-24 Regeneron Pharmaceuticals, Inc. Humanized non-human animals with restricted immunoglobulin heavy chain loci
CN103571872B (en) * 2012-08-09 2016-11-23 山东国际生物科技园发展有限公司 A kind of preparation method of the transgenic animal that can express people's antibody
PT2840892T (en) 2013-02-20 2018-07-20 Regeneron Pharma Non-human animals with modified immunoglobulin heavy chain sequences
PL2967013T3 (en) * 2013-03-13 2019-07-31 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
EP2967012B1 (en) 2013-03-14 2020-09-16 Erasmus University Medical Center Rotterdam Transgenic non-human mammal for antibody production
US9788534B2 (en) * 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
US9783618B2 (en) 2013-05-01 2017-10-10 Kymab Limited Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
US9783593B2 (en) * 2013-05-02 2017-10-10 Kymab Limited Antibodies, variable domains and chains tailored for human use
US11707056B2 (en) 2013-05-02 2023-07-25 Kymab Limited Animals, repertoires and methods
CN105683365A (en) 2013-10-01 2016-06-15 科马布有限公司 Animal models and therapeutic molecules
JP6479024B2 (en) 2014-01-24 2019-03-06 ザ チルドレンズ メディカル センター コーポレーション High-throughput mouse model for antibody affinity optimization
CA2941514A1 (en) 2014-03-21 2015-09-24 Regeneron Pharmaceuticals, Inc. Vl antigen binding proteins exhibiting distinct binding characteristics
JP6636498B2 (en) 2014-03-21 2020-01-29 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Non-human animals that make single domain binding proteins
JP2018500896A (en) * 2014-12-09 2018-01-18 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Non-human animal having humanized differentiation antigen group 274 gene
WO2016149678A1 (en) 2015-03-19 2016-09-22 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
CN106699888B (en) 2015-07-28 2020-11-06 上海昀怡健康科技发展有限公司 PD-1 antibody and preparation method and application thereof
JP2018535655A (en) 2015-09-29 2018-12-06 アムジエン・インコーポレーテツド ASGR inhibitor
CA3038720A1 (en) * 2016-11-04 2018-07-12 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered immunoglobulin lambda light chain locus
CA3099487A1 (en) 2017-07-20 2019-01-24 Nbe-Therapeutics Ag Human antibodies binding to ror2
CN110272490B (en) 2018-03-14 2021-05-14 上海开拓者生物医药有限公司 Targeted CTLA-4 antibody, preparation method and application thereof
CN112105641A (en) * 2018-03-19 2020-12-18 科塔生物治疗有限责任公司 Compositions and methods for modified B cell expression of redistributed biological agents
WO2019241122A1 (en) * 2018-06-13 2019-12-19 The Children's Medical Center Corporation Methods and compositions relating to high-throughput models for antibody discovery and/or optimization
CN111234018A (en) 2018-11-29 2020-06-05 上海开拓者生物医药有限公司 Fully human anti-GITR antibody and preparation method thereof
CN111253485A (en) 2018-11-30 2020-06-09 上海开拓者生物医药有限公司 Anti-human TIM-3 monoclonal antibody and application thereof
WO2020169755A2 (en) 2019-02-20 2020-08-27 Harbour Antibodies Bv Antibodies
WO2020247852A1 (en) 2019-06-07 2020-12-10 Amgen Inc. Bispecific binding constructs
EP3993623A1 (en) * 2019-07-01 2022-05-11 Trianni, Inc. Transgenic mammals and methods of use thereof
GB202003632D0 (en) 2020-03-12 2020-04-29 Harbour Antibodies Bv SARS-Cov-2 (SARS2, COVID-19) antibodies
EP4161969A1 (en) 2020-06-04 2023-04-12 Amgen Inc. Bispecific binding constructs
US20240010721A1 (en) 2020-09-03 2024-01-11 Harbour Biomed (Shanghai) Co., Ltd Ror1-targeting antibody or antigen-binding fragment thereof, preparation method therefor, and application thereof
WO2022120033A1 (en) 2020-12-03 2022-06-09 Amgen Inc. Immunoglobuline constructs with multiple binding domains
CN114685669A (en) 2020-12-30 2022-07-01 和铂医药(苏州)有限公司 Antibodies that bind TROP2 and uses thereof
WO2023036982A1 (en) 2021-09-10 2023-03-16 Harbour Antibodies Bv Anti-sars2-s antibodies
GB202112935D0 (en) 2021-09-10 2021-10-27 Harbour Antibodies Bv Sars-cov-2 (sars2, covid-19) heavy chain only antibodies

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
GB8904009D0 (en) 1989-02-22 1989-04-05 Celltech Ltd Vector
US6673986B1 (en) * 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
WO1993012227A1 (en) * 1991-12-17 1993-06-24 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US7041871B1 (en) * 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5770429A (en) * 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
AU781922B2 (en) * 1991-12-17 2005-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
DE4228162C1 (en) 1992-08-25 1994-01-13 Rajewsky Klaus Dr Method for replacing homologous gene segments from mammals in the germline of non-human mammals
CA2161351C (en) * 1993-04-26 2010-12-21 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
EP2314625B1 (en) * 1996-12-03 2014-05-07 Amgen Fremont Inc. Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
NZ525664A (en) * 2000-11-17 2008-08-29 Kirin Holdings Kk Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
GB0115256D0 (en) 2001-06-21 2001-08-15 Babraham Inst Mouse light chain locus
GB0228210D0 (en) * 2002-12-03 2003-01-08 Babraham Inst Single chain antibodies
GB2398784B (en) * 2003-02-26 2005-07-27 Babraham Inst Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
ES2473596T3 (en) * 2003-07-15 2014-07-07 Therapeutic Human Polyclonals, Inc. Humanized immunoglobulin loci
ITRM20030601A1 (en) * 2003-12-24 2005-06-25 Lay Line Genomics Spa METHOD FOR THE HUMANIZATION OF HUMANIZED ANTIBODIES AND ANTIBODIES WITH IT OBTAINED.
US7420099B2 (en) * 2004-04-22 2008-09-02 Kirin Holdings Kabushiki Kaisha Transgenic animals and uses thereof
JP2008512987A (en) 2004-07-22 2008-05-01 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム Binding molecule
GB2416768A (en) * 2004-07-22 2006-02-08 Univ Erasmus Heavy chain immunoglobulin complexes
EP1812578A2 (en) 2004-10-22 2007-08-01 Therapeutic Human Polyclonals, Inc. Suppression of endogenous immunoglobulin expression in non-human transgenic animals
EP1910418B1 (en) * 2005-08-03 2010-07-21 Therapeutic Human Polyclonals, Inc. Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin
AU2007219159B8 (en) 2006-01-25 2012-06-28 Roger Kingdon Craig Generation of heavy-chain only antibodies in transgenic animals
GB0601511D0 (en) * 2006-01-25 2006-03-08 Univ Erasmus Medical Ct Binding Molecules 2
GB0618345D0 (en) 2006-09-18 2006-10-25 Univ Erasmus Binding molecules
AU2007235496B2 (en) 2006-03-31 2013-11-21 E. R. Squibb & Sons, L.L.C. Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
PT2336329E (en) * 2007-06-01 2012-12-24 Omt Inc Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenis human idiotype antibodies
WO2009013620A2 (en) 2007-06-11 2009-01-29 Erasmus University Medical Center Rotterdam Homologous recombination
CN112680475A (en) * 2008-12-18 2021-04-20 伊拉兹马斯大学鹿特丹医学中心 Non-human transgenic animals expressing humanized antibodies and uses thereof
GB0905023D0 (en) 2009-03-24 2009-05-06 Univ Erasmus Medical Ct Binding molecules
ES2547142T5 (en) 2010-02-08 2021-12-09 Regeneron Pharma Mouse common light chain
SI2480675T1 (en) 2010-06-22 2016-08-31 Regeneron Pharmaceuticals, Inc. Mice expressing a light chain with human lambda variable and mouse constant regions
GB201122047D0 (en) * 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
EP2967012B1 (en) 2013-03-14 2020-09-16 Erasmus University Medical Center Rotterdam Transgenic non-human mammal for antibody production
CN114763558B (en) * 2021-01-14 2024-02-20 上海泰槿生物技术有限公司 Recombinant genome, non-human mammalian cell, and methods of producing and using the same

Also Published As

Publication number Publication date
WO2010070263A1 (en) 2010-06-24
US11877565B2 (en) 2024-01-23
CN112715482B (en) 2022-11-11
EP2379727A1 (en) 2011-10-26
JP2012512647A (en) 2012-06-07
US20130330771A1 (en) 2013-12-12
CN112626117A (en) 2021-04-09
BRPI0922479A2 (en) 2017-07-25
MX2011007660A (en) 2011-08-17
CN112690250B (en) 2024-03-08
TW201030143A (en) 2010-08-16
CN102292445A (en) 2011-12-21
EP2379727B1 (en) 2016-11-16
KR101711222B1 (en) 2017-02-28
SG172176A1 (en) 2011-07-28
KR20110125208A (en) 2011-11-18
CN112680475A (en) 2021-04-20
CN112690250A (en) 2021-04-23
AU2009329365B2 (en) 2016-01-14
CN107549118B (en) 2022-06-24
US20160295842A1 (en) 2016-10-13
DK2379727T3 (en) 2017-01-16
CN112715482A (en) 2021-04-30
ES2613730T3 (en) 2017-05-25
RU2011129459A (en) 2013-01-27
AU2009329365A1 (en) 2010-06-24
CA2747534A1 (en) 2010-06-24
JP5827127B2 (en) 2015-12-02
US20110314563A1 (en) 2011-12-22
CN107549118A (en) 2018-01-09
US9131669B2 (en) 2015-09-15
CA2747534C (en) 2020-08-18

Similar Documents

Publication Publication Date Title
SG10201400716PA (en) Non-human transgenic animals expressing humanised antibodies and use therof
EP2003960A4 (en) Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
LT3456190T (en) Antibody producing transgenic murine animal
ZA201104468B (en) Animal litters
IL241091B (en) Antibodies against fcrn and use thereof
PL2064325T3 (en) Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
EP2288623A4 (en) Method of generating single vl domain antibodies in transgenic animals
IL230771A (en) Human antibodies that bind to pcsk9
IL209142A0 (en) Anti-flt3 antibodies
IL224327B (en) Transgenic animals and methods of use
EP2448560A4 (en) Laboratory animal pulmonary dosing device
EP2433127A4 (en) Composite animal litter material and methods
EP2618656A4 (en) HUMAM SIRPAalpha TRANSGENIC ANIMALS AND THEIR METHODS OF USE
PL2367850T3 (en) Human anti tshr antibodies
IL212598A0 (en) Multipurpose ant bait
EP2388320A4 (en) Anti-hs6st2 antibodies and use thereof
GB0913894D0 (en) Animal attractant
ZA200806400B (en) Generation of heavy-chain only antibodies in transgenic animals
EP2322610A4 (en) Anti-human clcp1 antibody and use thereof
GB0805513D0 (en) Animal leash
ZA201204250B (en) Transgenic non-human animal and uses thereof
DE602009000147D1 (en) Bait device for use in fishing
ZA201001213B (en) Animal trapping and auctioning
GB0622145D0 (en) Transgenic non-human animal
HU3712U (en) Parrot harness and leash